Patch-level Tumor Classification in Digital Histopathology Images with Domain Adapted Deep Learning

Tackling the small data problem in medical image classification with artificial intelligence: a systematic review

Though medical imaging has seen a growing interest in AI research, training models require a large amount of data. In this domain, there are limited sets of data available as collecting new data is either not feasible or requires burdensome resources. Researchers are facing with the problem of small datasets and have to apply tricks to fight overfitting. 147 peer-reviewed articles were retrieved from PubMed, published in English, up until 31 July 2022 and articles were assessed by two independent reviewers. We followed the Preferred Reporting Items for Systematic reviews and Meta-Analyse (PRISMA) guidelines for the paper selection and 77 studies were regarded as eligible for the scope of this review. Adherence to reporting standards was assessed by using TRIPOD statement (transparent reporting of a multivariable prediction model for individual prognosis or diagnosis). To solve the small data issue transfer learning technique, basic data augmentation and generative adversarial network were applied in 75%, 69% and 14% of cases, respectively. More than 60% of the authors performed a binary classification given the data scarcity and the difficulty of the tasks. Concerning generalizability, only four studies explicitly stated an external validation of the developed model was carried out. Full access to all datasets and code was severely limited (unavailable in more than 80% of studies). Adherence to reporting standards was suboptimal (<50% adherence for 13 of 37 TRIPOD items). The goal of this review is to provide a comprehensive survey of recent advancements in dealing with small medical images samples size. Transparency and improve quality in publications as well as follow existing reporting standards are also supported.

FABNet: Fusion Attention Block and Transfer Learning for Laryngeal cancer Tumor Grading in P63 IHC Histopathology Images

Laryngeal cancer tumor (LCT) grading is a challenging task in P63 Immunohistochemical (IHC) histopathology images due to small differences between LCT levels in pathology images, the lack of precision in lesion regions of interest (LROIs) and the paucity of LCT pathology image samples. The key to solving the LCT grading problem is to transfer knowledge from other images and to identify more accurate LROIs, but the following problems occur: 1) transferring knowledge without a priori experience often causes negative transfer and creates a heavy workload due to the abundance of image types, and 2) convolutional neural networks (CNNs) constructing deep models by stacking cannot sufficiently identify LROIs, often deviate significantly from the LROIs focused on by experienced pathologists, and are prone to providing misleading second opinions. So we propose a novel fusion attention block network (FABNet) to address these problems. First, we propose a model transfer method based on clinical a priori experience and sample analysis (CPESA) that analyzes the transfer ability by integrating clinical a priori experience using indicators such as the relationship between the cancer onset location and morphology and the texture and staining degree of cell nuclei in histopathology images; our method further validates these indicators by the probability distribution of cancer image samples. Then, we propose a fusion attention block (FAB) structure, which can both provide an advanced non-uniform sparse representation of images and extract spatial relationship information between nuclei; consequently, the LROI can be more accurate and more relevant to pathologists. We conducted extensive experiments, compared with the best Baseline model, the classification accuracy is improved 25%, and It is demonstrated that FABNet performs better on different cancer pathology image datasets and outperforms other state of the art (SOTA) models.

Radiomics at a Glance: A Few Lessons Learned from Learning Approaches

Simple Summary

Radiomics has become a prominent component of medical imaging research and many studies show its specific value as a support tool for clinical decision-making processes. Radiomic data are typically analyzed with statistical and machine learning methods, which change depending on the disease context and the imaging modality. We found a certain bias in the literature towards the use of such methods and believe that this limitation may influence the capacity of producing accurate and reliable decisions. Therefore, in view of the relevance of various types of learning methods, we report their significance and discuss their unrevealed potential.

Abstract

Processing and modeling medical images have traditionally represented complex tasks requiring multidisciplinary collaboration. The advent of radiomics has assigned a central role to quantitative data analytics targeting medical image features algorithmically extracted from large volumes of images. Apart from the ultimate goal of supporting diagnostic, prognostic, and therapeutic decisions, radiomics is computationally attractive due to specific strengths: scalability, efficiency, and precision. Optimization is achieved by highly sophisticated statistical and machine learning algorithms, but it is especially deep learning that stands out as the leading inference approach. Various types of hybrid learning can be considered when building complex integrative approaches aimed to deliver gains in accuracy for both classification and prediction tasks. This perspective reviews some selected learning methods by focusing on both their significance for radiomics and their unveiled potential.

Resolution-agnostic tissue segmentation in whole-slide histopathology images with convolutional neural networks

Modern pathology diagnostics is being driven toward large scale digitization of microscopic tissue sections. A prerequisite for its safe implementation is the guarantee that all tissue present on a glass slide can also be found back in the digital image. Whole-slide scanners perform a tissue segmentation in a low resolution overview image to prevent inefficient high-resolution scanning of empty background areas. However, currently applied algorithms can fail in detecting all tissue regions.

In this study, we developed convolutional neural networks to distinguish tissue from background. We collected 100 whole-slide images of 10 tissue samples—staining categories from five medical centers for development and testing. Additionally, eight more images of eight unfamiliar categories were collected for testing only. We compared our fully-convolutional neural networks to three traditional methods on a range of resolution levels using Dice score and sensitivity.

We also tested whether a single neural network can perform equivalently to multiple networks, each specialized in a single resolution. Overall, our solutions outperformed the traditional methods on all the tested resolutions. The resolution-agnostic network achieved average Dice scores between 0.97 and 0.98 across the tested resolution levels, only 0.0069 less than the resolution-specific networks. Finally, its excellent generalization performance was demonstrated by achieving averages of 0.98 Dice score and 0.97 sensitivity on the eight unfamiliar images. A future study should test this network prospectively.

Translational AI and Deep Learning in Diagnostic Pathology

There has been an exponential growth in the application of AI in health and in pathology. This is resulting in the innovation of deep learning technologies that are specifically aimed at cellular imaging and practical applications that could transform diagnostic pathology. This paper reviews the different approaches to deep learning in pathology, the public grand challenges that have driven this innovation and a range of emerging applications in pathology. The translation of AI into clinical practice will require applications to be embedded seamlessly within digital pathology workflows, driving an integrated approach to diagnostics and providing pathologists with new tools that accelerate workflow and improve diagnostic consistency and reduce errors. The clearance of digital pathology for primary diagnosis in the US by some manufacturers provides the platform on which to deliver practical AI. AI and computational pathology will continue to mature as researchers, clinicians, industry, regulatory organizations and patient advocacy groups work together to innovate and deliver new technologies to health care providers: technologies which are better, faster, cheaper, more precise, and safe.